T. Herrin

发表

Further developments in the nonenzymic biogenetic-like steroid synthesis.

D. Rich, W. S. Johnson, T. Li, 1970, Journal of the American Chemical Society.

PREPARATION OF BIOLOGICALLY ACTIVE RISTOCETIN DERIVATIVES: REPLACEMENTS OF THE 1′-AMINO GROUP

S. Fesik, J. Mao, T. Herrin, 1985 .

Preparation of biologically active ristocetin derivatives: replacements of the 1'-amino group.

S. Fesik, J. Mao, T. Herrin, 1985, Journal of medicinal chemistry.

Synthesis and anti-herpes simplex activity of analogues of phosphonoacetic acid.

R. R. Bower, N. Shipkowitz, T. Herrin, 1977, Journal of medicinal chemistry.

Cyclobut-A and cyclobut-G: broad-spectrum antiviral agents with potential utility for the therapy of AIDS.

D. Norbeck, J. Erickson, H. Sham, 1990, Journal of medicinal chemistry.

Synthesis and antiviral activities of the major metabolites of the HIV protease inhibitor ABT-378 (Lopinavir).

A. Molla, S. Vasavanonda, D. Norbeck, 2001, Bioorganic & medicinal chemistry letters.

Synthesis and activities of the phosphonate isostere of the monophosphate of (±)cyclobut-G

D. Norbeck, H. Sham, J. Plattner, 1992 .

Synthesis of (±)-cycloprop-G, the cyclopropyl analogue of the broad spectrum antiviral agent cyclobut-G

D. Norbeck, H. Sham, J. Plattner, 1992 .

SYNTHESIS AND ANTI-HERPES SIMPLEX ACTIVITY OF ANALOGS OF PHOSPHONOACETIC ACID

R. R. Bower, N. Shipkowitz, J. Mao, 1977 .

Structure-activity studies on phosphonoacetate

N. Shipkowitz, R. Duff, J. Mao, 1985, Antimicrobial Agents and Chemotherapy.

Novel lopinavir analogues incorporating heterocyclic replacements of six-member cyclic urea--synthesis and structure-activity relationships.

S. Vasavanonda, D. Norbeck, H. Sham, 2004, Bioorganic & medicinal chemistry letters.

Acyl tetramic acids. 6. Synthesis of 3-dienoyl tetramic acids related to streptolydigin and tirandamycin

K. Rinehart, V. Lee, T. Herrin, 1978 .

A novel, picomolar inhibitor of human immunodeficiency virus type 1 protease.

A. Molla, S. Vasavanonda, N. Lyons, 1996, Journal of medicinal chemistry.

Novel azacyclic ureas that are potent inhibitors of HIV-1 protease.

A. Molla, S. Vasavanonda, D. Norbeck, 1996, Biochemical and Biophysical Research Communications - BBRC.